NIKA PHARM
Budget
€10 — €0
EP Access
0
accredited persons
Staff
3
1.5 FTE
EU Grants
None
Mission & Goals
Our organization operates in the pharmaceutical sector, focused on the distribution and marketing of safe, effective, and innovative healthcare products. Our mission is to improve public health and wellbeing by ensuring access to essential medicines across Kosovo and the wider Balkan region. We are committed to quality, regulatory compliance, and long-term partnerships with medical professionals and institutions.
EU Legislative Interests
This expression of interest targets EU policies and initiatives related to regional economic development, foreign direct investment (FDI) facilitation, green transition, and industrial value chain integration in the Western Balkans, particularly as outlined in the EU Growth Plan and Western Balkans Investment Framework (WBIF)."
Communication Activities
Communication activities include presentations of the investment projects to national and local institutions, public promotion through company channels (website and social media), as well as participation in regional economic development events and EU-related investment forums. The goal is to align the projects with EU policy objectives and ensure stakeholder engagement and visibility.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
The applicant is an independent private company and does not represent other members or third-party organisations. All interest representation activities, including participation in EU-funded initiatives and investment proposals, are carried out solely on behalf of the company. The company is not part of any federation, association or umbrella network. There are no affiliated branches or partners conducting such activities on its behalf.
Organisation Members
The applicant is a standalone private company and does not have any formal members or affiliated entities. All activities related to interest representation are carried out solely by the company itself.
Additional Information
The company has submitted three strategic investment proposals under the EU Call for Expression of Interest, related to pharmaceutical manufacturing, a private hospital, and a bottled water production facility. Three staff members are involved in these activities, each dedicating approximately 50% of their working time. Estimated annual costs reflect internal resources allocated to project preparation, institutional communication, and participation in EU-related initiatives.
Commissioner Meetings
No recorded meetings with EU commissioners.